Human-Derived Anti-BCMA CAR-T Injection

anti-BCMA CAR-T cell therapy · Hrain Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human-Derived Anti-BCMA CAR-T Injection, covering 2025-01-03 to 2025-01-03. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM [EARLY_Phase 1]

See pricing